BLYS

Welcome to the Brand page for “BLYS”, which is offered here for Proteins, nucleic acids and pharmaceutical preparations containing proteins and/or nucleic acids for the treatment of immune deficiency syndromes, cancer, infections, allergies and asthma, and for the enhancement of b cell and immunoglobin production following organ or bone marrow transplant, vaccine administration, immunosuppression, chemotherapy, antibiotic or gene therapy;.

Its status is currently believed to be active. Its class is unavailable. “BLYS” is believed to be currently owned by “HUMAN GENOME SCIENCES, INC.”